SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-19-064785
Filing Date
2019-11-15
Accepted
2019-11-15 17:01:31
Documents
3
Effectiveness Date
2019-11-15

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm1922907d2_defa14a.htm DEFA14A 18257
2 GRAPHIC image_002.jpg GRAPHIC 4956
3 GRAPHIC image_001.jpg GRAPHIC 3025
  Complete submission text file 0001104659-19-064785.txt   30771
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33357 | Film No.: 191225232
SIC: 2836 Biological Products, (No Diagnostic Substances)